Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00320385

Femme Homme

Extrait

This study will evaluate and compare the safety and efficacy of lapatinib in combination with trastuzumab versus lapatinib monotherapy in subjects with HER2-positive metastatic breast cancer.


Critère d'inclusion

  • Neoplasms, Breast


Liens